Literature DB >> 3177586

Stereopsis in presbyopes wearing monovision and simultaneous vision bifocal contact lenses.

E McGill1, P Erickson.   

Abstract

One of the advantages suggested for contact lens bifocals over monovision treatment of presbyopia is that there may be less impairment of binocular function. We evaluated nearpoint stereoposis on the Titmus stereotest for 10 presbyopic patients. Testing was done under five conditions; monovision and binocular correction with each of four marketed simultaneous bifocal contact lenses. Simultaneous vision bifocals tested produced at least as much reduction in stereopsis as monovision compared to baseline spectacle correction. Repeat testing of bifocal stereopsis with best near over-refraction suggested that a substantial portion of the stereo reduction could be attributed to insufficient effective adds with the bifocal contacts.

Entities:  

Mesh:

Year:  1988        PMID: 3177586     DOI: 10.1097/00006324-198808000-00005

Source DB:  PubMed          Journal:  Am J Optom Physiol Opt        ISSN: 0093-7002


  4 in total

1.  Quantification of ghosting produced with presbyopic contact lens correction.

Authors:  Pete S Kollbaum; BoKaye M Dietmeier; Meredith E Jansen; Martin E Rickert
Journal:  Eye Contact Lens       Date:  2012-07       Impact factor: 2.018

2.  Monovision and the Misperception of Motion.

Authors:  Johannes Burge; Victor Rodriguez-Lopez; Carlos Dorronsoro
Journal:  Curr Biol       Date:  2019-07-25       Impact factor: 10.834

3.  The effect of different monovision contact lens powers on the visual function of emmetropic presbyopic patients (an American Ophthalmological Society thesis).

Authors:  Daniel S Durrie
Journal:  Trans Am Ophthalmol Soc       Date:  2006

4.  Modified monovision with spherical aberration to improve presbyopic through-focus visual performance.

Authors:  Len Zheleznyak; Ramkumar Sabesan; Je-Sun Oh; Scott MacRae; Geunyoung Yoon
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-05-03       Impact factor: 4.799

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.